相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment options in type-2 low asthma
Timothy S. C. Hinks et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
JAK inhibitors for asthma
Steve N. Georas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Efficient, Protecting Group Free Kilogram-Scale Synthesis of the JAK1 Inhibitor GDC-4379
Andreas Stumpf et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2021)
Long-term corticosteroid use, adrenal insufficiency and the need for steroid-sparing treatment in adult severe asthma
M. Gurnell et al.
JOURNAL OF INTERNAL MEDICINE (2021)
Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial
Irene E. Braithwaite et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
The safety of JAK-1 inhibitors
Benjamin Clarke et al.
RHEUMATOLOGY (2021)
Selective Janus kinase inhibition preserves interferon-λ-mediated antiviral responses
Daniel Schnepf et al.
SCIENCE IMMUNOLOGY (2021)
Surfactant protein A modulates the activities of the JAK/STAT pathway in suppressing Th1 and Th17 polarization in murine OVA-induced allergic asthma
Xi Chen et al.
LABORATORY INVESTIGATION (2021)
Mechanisms and therapeutic strategies for non-T2 asthma
Eric Sze et al.
ALLERGY (2020)
TD-8236, a lung-selective inhaled pan-JAK inhibitor, inhibits gene expression related to severe asthma and exhaled nitric oxide (FeNO), in 3-D airway epithelium liquid interface (ALI) cultures derived from asthmatic donors
Elad Kaufman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
How can we minimise the use of regular oral corticosteroids in asthma?
Arnaud Bourdin et al.
EUROPEAN RESPIRATORY REVIEW (2020)
Prediction of response to biological treatment with monoclonal antibodies in severe asthma
J. A. Kroes et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms
Elin Boger et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2019)
Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
Masayoshi Harigai
RHEUMATOLOGY (2019)
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
Anniina T. Virtanen et al.
BIODRUGS (2019)
Novel Inhaled Pan-JAK Inhibitor, LAS194046, Reduces Allergen-Induced Airway Inflammation, Late Asthmatic Response, and pSTAT Activation in Brown Norway Rats
Marta Calbet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma
Mark Zak et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Magnolol exerts anti-asthmatic effects by regulating Janus kinase-signal transduction and activation of transcription and Notch signaling pathways and modulating Th1/Th2/Th17 cytokines in ovalbumin-sensitized asthmatic mice
Qi Huang et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2019)
Targeting cell signaling in allergic asthma
Seyyed Shamsadin Athari
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs
Massimo Gadina et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies
J. Mark FitzGerald et al.
LANCET RESPIRATORY MEDICINE (2018)
Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment
Stephanie Chen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
The molecular details of cytokine signaling via the JAK/STAT pathway
Rhiannon Morris et al.
PROTEIN SCIENCE (2018)
Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma
Hart S. Dengler et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Signaling and Function of Interleukin-2 in T Lymphocytes
Sarah H. Ross et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Th9 and other IL-9-producing cells in allergic asthma
Sonja Koch et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
Diane Lefaudeux et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Tezepelumab in Adults with Uncontrolled Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Farhad Seif et al.
CELL COMMUNICATION AND SIGNALING (2017)
Interleukin-2-Dependent Allergen-Specific Tissue-Resident Memory Cells Drive Asthma
Brian D. Hondowicz et al.
IMMUNITY (2016)
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Sally Wenzel et al.
LANCET (2016)
Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs
E. Boger et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Asthma
Stephen T. Holgate et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses
Shigeru Ashino et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling
Jun Zhong et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2014)
Optimisation of DMPK by the Inhaled Route: Challenges and Approaches
Anne E. Cooper et al.
CURRENT DRUG METABOLISM (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
A role for sensory nerves in the late asthmatic response
Kristof Raemdonck et al.
THORAX (2012)
Postnatal growth of tracheobronchial airways of Sprague-Dawley rats
DongYoub Lee et al.
JOURNAL OF ANATOMY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Wendy C. Moore et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Distinct Signal Codes Generate Dendritic Cell Functional Plasticity
Kazuhiko Arima et al.
SCIENCE SIGNALING (2010)
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system
Sherry L. LaPorte et al.
CELL (2008)
The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia
Elizabeth Kudlacz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease
Hubert Chen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment
Stephen P. Peters et al.
RESPIRATORY MEDICINE (2006)
Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs
V Codrons et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats
DJ Hele et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
分享论文
